NIST GCR 01-815
A Guide to the EU Medical Device Directive
If the product is a Class I (sterile/measurement function), IIa, IIb, and/or III, the manufacturer will need to prepare for a Notified Body audit in accordance with the following Annexes:
X. Authorized Representation and Competent Authority Registration
The Medical Device Directive requires the appointment of an Authorized Representative for Europe in the event the manufacturer is not established within the European Economic Area (EEA). (See NIST SP 951 A Guide to EU Standards and Conformity Assessment, Page 23.)
The Directive requires that the manufacturer be listed on the label and/or packaging, and in the Instructions and Declaration of Conformity
A non-European resident manufacturer may select an agent, distributor, or a non-commercially involved representative to take up the responsibilities of an Authorized Representative.
The name of the manufacturer and the device must be notified to the Competent Authority in which the manufacturer has his or her registered place of business, the address of his registered place of business, and the description of the devices concerned.
In addition, the manufacturer keeps the Technical File available for review by Competent Authorities (the Department (Ministry) of Health of a Member State), and plays an essential role in vigilance procedures.
XI. CE Marking
CE marking (See NIST SP 951 A Guide to EU Standards and Conformity Assessment, Page 17.)
The manufacturer is obliged to place the CE Marking on the medical device. Annex XII of the Directive instructs the manufacturer on the placing of the CE Marking.
